Education
About Us
Working with TipRanks
Follow Us
BridgeBio Oncology Therapeutics (BBOT)
NASDAQ:BBOT
Technical Sentiment
Overall Consensus
Neutral
8Bullish
6Neutral
8Bearish
Technical Analysis Consensus
Neutral
2Bullish
6Neutral
2Bearish
Moving Average Consensus
Neutral
6Bullish
0Neutral
6Bearish
BridgeBio Oncology Therapeutics’s (BBOT) Moving Averages Convergence Divergence (MACD) indicator is 0.20, suggesting BridgeBio Oncology Therapeutics is a Buy.
BridgeBio Oncology Therapeutics’s (BBOT) 20-Day exponential moving average is 12.37, while BridgeBio Oncology Therapeutics’s (BBOT) share price is $12.18, making it a Sell.
BridgeBio Oncology Therapeutics’s (BBOT) 50-Day exponential moving average is 11.88, while BridgeBio Oncology Therapeutics’s (BBOT) share price is $12.18, making it a Buy.
BridgeBio Oncology Therapeutics (BBOT) Pivot Points
Classic
11.55
11.92
12.14
12.52
12.74
13.11
13.33
Fibonacci
11.92
12.15
12.29
12.52
12.74
12.88
13.11
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.
BridgeBio Oncology Therapeutics (BBOT) Moving Averages
MA5
12.28Sell
12.37Sell
MA10
12.68Sell
12.47Sell
MA20
12.50Sell
12.37Sell
MA50
11.94Buy
11.88Buy
MA100
11.07Buy
11.43Buy
MA200
10.94Buy
11.15Buy
BridgeBio Oncology Therapeutics’s (BBOT) 10-Day exponential moving average is 12.47, while BridgeBio Oncology Therapeutics’s (BBOT) share price is $12.18, making it a Sell.
BridgeBio Oncology Therapeutics’s (BBOT) 100-Day exponential moving average is 11.43, while BridgeBio Oncology Therapeutics’s (BBOT) share price is $12.18, making it a Buy.
BridgeBio Oncology Therapeutics’s (BBOT) stock price is $12.18 and BridgeBio Oncology Therapeutics’s (BBOT) 50-day simple moving average is 11.94, creating a Buy signal.
BridgeBio Oncology Therapeutics’s (BBOT) stock price is $12.18 and BridgeBio Oncology Therapeutics’s (BBOT) 100-day simple moving average is 11.07, creating a Buy signal.
BridgeBio Oncology Therapeutics’s (BBOT) stock price is $12.18 and BridgeBio Oncology Therapeutics’s (BBOT) 200-day simple moving average is 10.94, creating a Buy signal.
BridgeBio Oncology Therapeutics (BBOT) Technical Indicators
RSI (14)
49.14
Neutral
STOCH (9,6)
21.52
Neutral
STOCHRSI (14)
21.52
Neutral
MACD (12,26)
0.20
Buy
ADX (14)
27.03
Neutral
Williams %R
-82.78
Buy
CCI (14)
-44.17
Neutral
ATR (14)
0.86
-
Ultimate Oscillator
34.20
Neutral
ROC
-0.57
Sell
BridgeBio Oncology Therapeutics’s (BBOT) Relative Strength Index (RSI) is 49.14, creating a Neutral signal.
BridgeBio Oncology Therapeutics’s (BBOT) Trend Strength Indicator (ADX) is 27.03, creating a Neutral signal.
BridgeBio Oncology Therapeutics’s (BBOT) Commodity Channel Index (CCI) is -44.17, creating a Neutral signal.
BridgeBio Oncology Therapeutics’s (BBOT) Price Rate of Change (ROC) is -0.57, creating a Sell signal.
FAQ
Is BBOT a Buy, Hold, or Sell?
Based on BBOT’s technical indicators, BBOT is a Hold.
What is BBOT’s RSI (14)?
BBOT’s RSI (14) is 49.14, which suggests BBOT is a Neutral.
What is BBOT’s MACD?
BBOT’s MACD is 0.20, which suggests BBOT is a Buy.
What is BBOT’s 5-day moving average?
BBOT’s 5-day moving average is 12.28, which suggests BBOT is a Sell.
What is BBOT’s 20-day moving average?
BBOT 20-day moving average is 12.50, which suggests BBOT is a Sell.
What is BBOT’s 50-day moving average?
BBOT’s 50-day moving average is 11.94, which suggests BBOT is a Buy.
What is BBOT’s 200-day moving average?
BBOT’s 200-day moving average is 10.94, which suggests BBOT is a Buy.
What is BBOT’s Williams % R (14)?
BBOT’s Williams % R (14) is -82.78, which suggests BBOT is a Buy.
What is BBOT’s CCI (14)?
BBOT’s CCI (14) is -44.17, which suggests BBOT is a Neutral.